A detailed history of Heirloom Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Heirloom Wealth Management holds 8,056 shares of LLY stock, worth $6.01 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares
8,056
Previous 7,737 4.12%
Holding current value
$6.01 Million
Previous $7 Million 1.9%
% of portfolio
2.32%
Previous 2.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $246,312 - $306,246
319 Added 4.12%
8,056 $7.14 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $79,010 - $99,085
109 Added 1.43%
7,737 $7 Million
Q1 2024

Apr 24, 2024

BUY
$592.2 - $792.28 $101,266 - $135,479
171 Added 2.29%
7,628 $5.93 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $3.92 Million - $4.62 Million
7,457 New
7,457 $4.35 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Heirloom Wealth Management Portfolio

Follow Heirloom Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heirloom Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Heirloom Wealth Management with notifications on news.